Abstract
Annovera (segesterone acetate and ethinyl estradiol vaginal system) is a US Food and Drug Administration FDA-approved long-lasting, reversible contraceptive that is fully administered by the user and does not require a procedure for insertion or removal. The vaginal system is in the shape of a ring and contains low doses of a novel progestin, egesterone acetate, and ethinyl estradiol. It is made of silicone and is fully pliable and flexible. The vaginal system is reusable for 13 cycles, using a 21 days in/7 days out regimen, providing women with the ability to control their fertility. Particularly now during the COVID-19 pandemic when access to contraception has been further reduced, patients may benefit from a method that is both long-lasting and patient-controlled.
Highlights
45% of pregnancies in the United States are unintended [1]
It has been found that patients who receive a 6 month or greater supply of contraception have higher rates of contraceptive continuation and adherence [6,10]. These findings suggest that the pharmacist prescribing of contraception allows for an improved access to birth control methods, especially in underserved populations, and provides a promising strategy to promote consistent use of contraception [11]
The results suggest that the ring surface does not promote the proliferation of microorganisms, most notably, Staphlococcus aureus, which has been suggested as a causative factor of toxic shock syndrome [27]
Summary
45% of pregnancies in the United States are unintended [1]. This high rate of unintended pregnancies underscores the need to develop contraceptive methods that meet the needs of women. Given the limitations associated with these methods, women may benefit from a contraceptive option that is long-lasting, patient-controlled, and procedure-free Another strategy to improve patient access to contraception and subsequently reduce unintended pregnancies has been to implement legislation to expand the scope of pharmacists, allowing them to directly prescribe and dispense hormonal contraception without a medical prescription [9]. It has been found that patients who receive a 6 month or greater supply of contraception have higher rates of contraceptive continuation and adherence [6,10] These findings suggest that the pharmacist prescribing of contraception allows for an improved access to birth control methods, especially in underserved populations, and provides a promising strategy to promote consistent use of contraception [11]. This article will review the clinical data supporting Annovera and provide best practices for patient counseling tailored to pharmacists
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
